Senju DRC A Double-Masked, Randomized, Multicenter, Placebo-Controlled, Parallel-Group Study to Assess the Safety, Tolerability, and Efficacy of MT-0814 for the Treatment of Patients with Age-Related Macular Degeneration

Administered By

Contributors

Start/End

  • April 11, 2019 - July 31, 2021